Caffeine · Evidence identifiers checked 2026-10-11 · Version 0.1.0 · Not yet reviewed by a clinician
Energy Drinks: What the Evidence Says About the Load You Are Taking
What reviews found about adverse effects and blood pressure, why the same caffeine can sit in three different product categories, and how to total up a day.
Energy drinks are not just coffee in a can. A systematic review and meta-analysis found the commonest adverse events in adults were jitteriness or restlessness, insomnia and stomach upset, and that energy drinks increased the odds of insomnia and jitteriness compared with controls; the authors recommend avoiding frequent use and mixing with alcohol. Reviews of cardiovascular measures found small rises in systolic and diastolic blood pressure, and a separate trial found both tested drinks prolonged the corrected QT interval more than placebo. Confusingly, these products are sold as beverages, as energy shots regulated as supplements, and as pills, and the caffeine content of the drinks measured in one study ranged from 10 to 67 mg per 100 mL. If you drink them, the useful step is to total up a whole day and compare it with the 400 mg figure the adverse-effects review found no overt adverse effects up to in healthy adults.
Not medical advice. This is a plain-language summary of published research for generally healthy adults. It is AI-drafted, has not been reviewed by a clinician, and nothing here diagnoses or treats anything.
What the evidence supports
In adults, the commonest adverse events with energy drinks were jitteriness or restlessness (29.8%), insomnia (24.7%) and stomach upset (21.6%); energy drinks raised the odds of insomnia (OR 5.02) and jitteriness (OR 3.52) versus controls. c-01
Energy drinks raised systolic blood pressure by about 4.7 mmHg and diastolic by about 4.5 mmHg in a meta-analysis of acute trials; resting heart rate and QT interval did not change significantly there, but a separate trial found both tested drinks prolonged the corrected QT interval more than placebo. c-02c-03
Products labelled as supplements can contain much more caffeine than drinks regulated as beverages, and one study found 10 to 67 mg per 100 mL across drinks, with 84% matching their labels. c-04c-05
A systematic review of caffeine in healthy adults found no overt adverse cardiovascular, behavioural, reproductive, acute or bone effects at up to 400 mg a day, which is the figure to total your day against. c-06
One next step: Total up every caffeine source you had yesterday, including energy products, and compare it with 400 mg.
The short version
What the adverse-event data show
A systematic review and meta-analysis pooled what happens to adults who drink energy drinks. The commonest reported adverse events were jitteriness or restlessness in about 30%, insomnia in about 25%, and stomach upset in about 22%. Compared with controls, energy drinks raised the odds of insomnia more than fivefold and jitteriness about three and a half times. The authors' own recommendation was to avoid frequent use, defined loosely as five to seven a week, and to avoid mixing with alcohol.
A meta-analysis of acute trials found small but measurable rises: systolic blood pressure up about 4.7 mmHg an hour after, diastolic up about 4.5 mmHg at two hours, and increased cardiac output. Resting heart rate and the QT interval did not change significantly in that analysis, and the authors graded the evidence moderate for systolic and low for diastolic, noting that eleven of the included trials had some concerns and six were at high risk of bias.
A separate controlled study of high-volume consumption found both tested drinks prolonged the corrected QT interval more than placebo and raised blood pressure. Two studies measuring related things differently is not a contradiction, but it is a reason not to quote either number as settled.
Caffeine content in one product survey ranged from 10 to 67 mg per 100 mL, and 84% of drinks matched their labels. That spread means a 500 mL can could hold anything from about 50 mg to well over 300 mg. The regulatory picture makes it worse: in the US these products are sold as conventional beverages, as energy shots regulated as dietary supplements, and as pills, and supplement-regulated products can contain much more caffeine per serving than beverage-regulated ones.
The practical consequence is that 'one can' is not a unit. The panel is.
A systematic review of caffeine in healthy adults found no overt adverse cardiovascular, behavioural, reproductive, acute or bone effects at up to 400 mg a day. That figure is about caffeine from any source, so coffee, tea, energy drinks, shots and pre-workout powders all count toward it. It also says nothing about sleep timing, which a separate body of evidence handles separately.
Three common beliefs, checked against the sources behind this page.
Pick what you believe first; the evidence answer is revealed after, so you can see where your assumption and the studies part company. Nothing is scored against you.
Energy drinks are basically strong coffee.
They can be. Product testing found 10 to 67 mg of caffeine per 100 mL, and products regulated as supplements may contain much more than beverage-regulated drinks. Two similar cans can differ several-fold, so the comparison only holds once you read the panel.
No source here tested 'one can a day' as a category. The adverse-event review linked frequent use (5-7 a week) with jitteriness and insomnia, and the 400 mg caffeine review found no overt adverse effects up to that total from any source. Whether one can is harmless depends on its content and what else you consumed.
Caffeine up to 400 mg a day showed no overt adverse effects in healthy adults; you cannot use that without a total. Certainty: moderate. c-06c-04
Cut frequency, keep the habit(1 min a day; $0)
Low
The adverse-event review recommends avoiding frequent use, roughly 5 to 7 a week. Certainty: moderate. c-01c-02
Switch to a known dose(5 min a day; similar)
Medium
Product caffeine ranged from 10 to 67 mg per 100 mL, so a known cup removes the guessing. Certainty: low. c-04c-05
Stop for two weeks(0 min; saves money)
Medium
Adverse events included insomnia and jitteriness; a break tells you whether you had them. Certainty: low. c-01
Total your day first
Write down every caffeine source for one day, read the panels, and add them up. Most people are surprised by which product contributes most. This is the option every other choice depends on.
Requires reading labels honestly, including supplements and pre-workout.
Keep energy drinks for specific occasions and cap the weekly count. The insomnia and jitteriness odds in the review were associated with use patterns, so frequency is the lever with the clearest evidence behind it.
You still get the acute blood pressure rise on the days you do drink them.
Replace energy drinks with coffee or tea whose content you have measured once. You keep the caffeine and lose the uncertainty, which is most of what makes energy products hard to manage.
Two weeks off all energy products, then note sleep and jitteriness. Caffeine withdrawal can cause headaches in the first days, so expect that and plan around it.
Withdrawal headaches and a few hard mornings; not suitable if you need to be alert-critical at work in week one.
Effort and cost are editorial estimates, not measurements. Each option links to the evidence behind it.
Your caffeine ceiling plan
Set one daily ceiling that includes every source, then decide where energy products fit inside it.
Cautions and limits
Read this before trying anything
This page is for generally healthy adults. It is not advice for anyone with a heart rhythm condition, high blood pressure, anxiety or a sleep disorder.
Do not mix energy drinks with alcohol; the adverse-effects review recommends against it.
Do not stack energy drinks with pre-workout powders, caffeine pills or other supplements without totalling the caffeine first.
If you feel palpitations, chest pain, severe anxiety or faintness after a caffeinated product, seek medical attention.
This page is not written for
people under 18, for whom the evidence base is limited and guidance differs
people who are pregnant or breastfeeding, who should ask their clinician about caffeine limits
people with a diagnosed arrhythmia, uncontrolled hypertension, an anxiety disorder or a sleep disorder
anyone taking medication that interacts with caffeine, without checking with a pharmacist
Talk to a clinician if
You have chest pain, a racing or irregular heartbeat, or you faint after a caffeinated product: get urgent medical care.
You cannot get through the day without multiple energy drinks: that is worth discussing with a clinician.
Companion tools
Optional. This article works on its own, and you don't need either tool.
Add up every caffeine source in a day, including energy drinks and shots, and show where you sit against a 400 mg ceiling.
Free: full day total across five sources; position against the 400 mg reference point; text export and print; all citations and cautions Plus (optional, $5 one-time, price being tested): calendar (.ics) cut-off reminders; unlimited share images; share card without the 'Made with CortexLit' footer Works offline. No account. Every source and caution stays free.
Convert a product panel into a milligram total and a per-day count, and flag stacking and alcohol mixing.
Free: per-serving and per-day conversion; stacking and alcohol-mixing flags; text export and print; all citations and cautions Plus (optional, $5 one-time, price being tested): calendar (.ics) reminders; unlimited share images; share card without the 'Made with CortexLit' footer Works offline. No account. Every source and caution stays free.
Commercial disclosure: The companion apps have an optional paid Plus tier. All evidence, cautions, and the main takeaway are free. No affiliate links, no sponsors. Plus checkout isn't live yet.
Evidence cards
Each card links a claim from this page to its sources. "Certainty" is our informal editorial judgement of how sure we can be, based on study design, size, consistency, and how closely it fits everyday life. Sources were weighted by type: Cochrane and systematic reviews 1.0, guidelines 0.9, randomized trials 0.8, observational studies 0.5, lab, mechanism or animal work 0.2. That ranking isn't the same thing as certainty.
c-01 In a systematic review and meta-analysis, frequently reported adverse events in adults were jitteriness or restlessness (29.8%), insomnia (24.7%) and stomach upset (21.6%). Energy drinks increased the odds of insomnia (OR 5.02) and jitteriness (OR 3.52) compared with controls, and the authors recommend avoiding frequent energy drink use (5 to 7 a week) and mixing them with alcohol.
Certainty: moderateHuman trials (cause and effect)
Who was studied, what was found, and the limits
Who: Adults in trials and studies pooled in a systematic review and meta-analysis Measured: Adverse events and odds versus controls Finding: Jitteriness 29.8%, insomnia 24.7%, stomach upset 21.6%; insomnia OR 5.02, jitteriness OR 3.52
Why this certainty: A systematic review with meta-analysis, the highest-weight source type used here. (Informal editorial assessment, not a formal GRADE rating.)
Limits: Adverse-event reporting varies between studies; 'frequent use' is defined loosely. Applies to: How often you drink them, not whether one can is fatal.
Identifier carried over from the 2026-10-11 abstract-level verification batch; not re-queried in this run. Source record
c-02 In a meta-analysis of acute trials in healthy adults, energy drinks raised systolic blood pressure by 4.71 mmHg at 60 to 80 minutes (GRADE moderate) and diastolic blood pressure by 4.51 mmHg at 120 minutes (GRADE low), and increased cardiac output. Resting heart rate and QT interval did not change significantly. Eleven trials had some concerns and six were at high risk of bias.
Certainty: moderateHuman trials (cause and effect)
Who was studied, what was found, and the limits
Who: Healthy adults in acute randomised trials Measured: Blood pressure, heart rate, QT interval, cardiac output Finding: Systolic +4.71 mmHg, diastolic +4.51 mmHg; no significant heart rate or QT change
Why this certainty: A meta-analysis with GRADE ratings, though the authors flag risk of bias in many included trials. (Informal editorial assessment, not a formal GRADE rating.)
Limits: Acute measures in healthy adults; bias concerns in a substantial share of trials. Applies to: Short-term cardiovascular load, especially with repeated use.
Identifier carried over from the 2026-10-11 abstract-level verification batch; not re-queried in this run. Source record
c-03 In a controlled study of high-volume consumption, both tested energy drinks prolonged the corrected QT interval more than placebo (+17.9 and +19.6 ms versus +11.9 ms) and raised blood pressure.
Certainty: lowHuman trials (cause and effect)
Who was studied, what was found, and the limits
Who: Healthy adults given high-volume energy drink consumption Measured: Electrocardiographic measures and blood pressure Finding: QTc prolonged by +17.9 and +19.6 ms versus +11.9 ms with placebo
Why this certainty: A controlled comparison, but a single study at high volume, and QTc changes of this size are not by themselves a clinical event. (Informal editorial assessment, not a formal GRADE rating.)
Limits: One study; high-volume dosing; short follow-up. Applies to: Why volume and stacking matter more than a single can.
Identifier carried over from the 2026-10-11 abstract-level verification batch; not re-queried in this run. Source record
c-04 In an analysis of energy drinks marketed in one country, 84% of drinks matched their labelled caffeine content, with 10 to 67 mg per 100 mL. The authors advise avoiding multiple servings in a short time and note that products labelled as supplements may contain much more caffeine than drinks regulated as beverages.
Certainty: lowObservational (association only)
Who was studied, what was found, and the limits
Who: Energy drink products tested against their labels Measured: Caffeine content per 100 mL Finding: 10 to 67 mg per 100 mL; 84% matched labels
Why this certainty: Direct product measurement, but in one market, and not a health outcome. (Informal editorial assessment, not a formal GRADE rating.)
Limits: One country's products; contents vary by brand and batch. Applies to: Why you must read the panel rather than assume a standard can.
Identifier carried over from the 2026-10-11 abstract-level verification batch; not re-queried in this run. Source record
c-05 There is no consistent US definition of energy products: they are sold as conventional beverages, as energy shots regulated as dietary supplements, and as pills. About 2.7% of the US population used them, most often men aged 19 to 30, and sales and emergency department visits involving these products appeared to be rising.
Certainty: lowObservational (association only)
Who was studied, what was found, and the limits
Who: US market and consumption data Measured: Product categories, use prevalence and trends Finding: Three regulatory categories; 2.7% of the population used them
Why this certainty: Descriptive market and surveillance data, the lowest-weight evidence type used here. (Informal editorial assessment, not a formal GRADE rating.)
Limits: Descriptive; does not establish causation for emergency visits. Applies to: Why two similar-looking products can carry very different caffeine loads.
Identifier carried over from the 2026-10-11 abstract-level verification batch; not re-queried in this run. Source record
c-06 A systematic review of caffeine consumption in healthy adults found the evidence generally supports that up to 400 mg a day is not associated with overt adverse cardiovascular, behavioural, reproductive, acute or bone effects; data are limited for children and teens and more research is needed in sensitive groups.
Who: Healthy adults across the evidence pooled in a systematic review Measured: Cardiovascular, behavioural, reproductive, acute and bone effects Finding: No overt adverse effects at up to 400 mg a day
Why this certainty: A systematic review covering many outcomes, though 'no overt adverse effects' is not the same as proven safety in every individual. (Informal editorial assessment, not a formal GRADE rating.)
Limits: Healthy adults; limited data for young people, pregnancy and sensitive groups. Applies to: The daily ceiling to total your intake against.
Identifier carried over from the 2026-10-11 abstract-level verification batch; not re-queried in this run. Source record
Where studies disagree
Does caffeine from energy drinks affect the QT interval?: A meta-analysis of acute trials found no significant change in QT interval, while a controlled study of high-volume consumption found both tested drinks prolonged corrected QT more than placebo. The difference is consistent with dose: the trial used high volume, the pooled trials did not. (src-02, src-03)
Sources for this entry
Every identifier below was verified against PubMed on 2026-10-11 in an earlier batch. This run carried the identifiers over rather than re-querying them, and no retraction database was checked. Verification was at abstract level; full text was not read.
Nadeem 2021 Nadeem IM, Shanmugaraj A, Sakha S, et al. Energy Drinks and Their Adverse Health Effects: A Systematic Review and Meta-analysis. Sports Health. 2021;13(3):265-277. doi:10.1177/1941738120949181. PMID: 33211984. PMID 33211984 · systematic review meta analysis · confidence weight 1.0 · abstract level
In adults, frequently reported adverse events were jitteriness or restlessness (29.8%), insomnia (24.7%) and stomach upset (21.6%). Energy drinks increased the odds of insomnia (OR 5.02) and jitteriness (OR 3.52) compared with controls. The authors recommend avoiding frequent energy drink use (5-7 a week) and mixing them with alcohol.
Gualberto 2024 Gualberto PIB, Benvindo VV, Waclawovsky G, et al. Acute effects of energy drink consumption on cardiovascular parameters in healthy adults: a systematic review and meta-analysis of randomized clinical trials. Nutr Rev. 2024;82(8):1028-1045. doi:10.1093/nutrit/nuad112. PMID: 37695306. PMID 37695306 · systematic review meta analysis · confidence weight 1.0 · abstract level
Energy drinks raised systolic blood pressure (4.71 mmHg at 60-80 minutes; GRADE moderate), diastolic blood pressure (4.51 mmHg at 120 minutes; GRADE low) and cardiac output. Resting heart rate and QT interval didn't change significantly. 11 trials had some concerns and 6 were at high risk of bias.
Shah 2019 Shah SA, Szeto AH, Farewell R, et al. Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial. J Am Heart Assoc. 2019;8(11):e011318. doi:10.1161/JAHA.118.011318. PMID: 31137991. PMID 31137991 · randomized controlled trial · confidence weight 0.8 · abstract level
Both energy drinks prolonged the corrected QT interval (a heart rhythm measure) more than placebo (+17.9 and +19.6 ms vs +11.9 ms) and raised blood pressure.
da 2022 da Costa BRB, El Haddad LP, De Martinis BS. Caffeine content of energy drinks marketed in Brazil. Drug Test Anal. 2022;14(9):1660-1664. doi:10.1002/dta.3323. PMID: 35595544. PMID 35595544 · observational study · confidence weight 0.5 · abstract level
84% of drinks matched their labeled caffeine content, with 10 to 67 mg per 100 mL. The authors advise avoiding multiple servings in a short time and note that products labeled as supplements may contain much more caffeine than drinks regulated as beverages.
Bailey 2014 Bailey RL, Saldanha LG, Dwyer JT. Estimating caffeine intake from energy drinks and dietary supplements in the United States. Nutr Rev. 2014;72 Suppl 1(Suppl 1):9-13. doi:10.1111/nure.12138. PMID: 25293539. PMID 25293539 · narrative review · confidence weight 0.2 · abstract level
There's no consistent US definition of energy products: they're sold as beverages (conventional foods), as energy shots (dietary supplements) and as pills. Sales and emergency room visits involving these products appeared to be rising. About 2.7% of the US population used them, most often men aged 19 to 30.
Wikoff 2017 Wikoff D, Welsh BT, Henderson R, et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol. 2017;109(Pt 1):585-648. doi:10.1016/j.fct.2017.04.002. PMID: 28438661. PMID 28438661 · systematic review · confidence weight 1.0 · abstract level
The evidence generally supports that up to 400 mg of caffeine a day in healthy adults isn't associated with overt adverse cardiovascular, behavioral, reproductive, acute or bone effects. Limited data exist for children and teens, and more research is needed on sensitive groups.